Explore Indian, Eyes and more!

As U.S. rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters

rep eyes global IP, India lets local pharmas export copies of on-patent Bayer blockbusters

QuintilesIMS’ new software unifies pharma commercial teams in one place

QuintilesIMS’ new software unifies pharma commercial teams in one place

Oral arguments in CRISPR patent case expected to be 'fight to the death'

Oral arguments in CRISPR patent case expected to be 'fight to the death'

Oral arguments in CRISPR patent case expected to be ‘fight to the death’

Challenge to UK Humira patent begins

Samsung Bioepis’ legal challenge to patents on AbbVie’s big-selling inflammatory diseases drug, Humira is beginning in the UK Patent Court.

Debate Over High-Priced Orphan Drugs Spending Intensifies : Shots - Health News : NPR

How Much Do Drugs For Rare Diseases Add To Health Care Spending?

Clinical trials of autism treatments are fertile ground for the placebo effect. Bryan King explains how the field must move forward to better evaluate treatments.

GSK: Costa Rican Panadol plant closure will eliminate 60 jobs

GSK says the closing of its Costa Rica manufacturing facility is necessary to ensure the long-term viability of its consumer healthcare business.

More states pour into generics price-fixing probe, suing Mylan, Teva and others | FiercePharma

More states pour into generics price-fixing probe, suing Mylan, Teva and others | FiercePharma

Spain plays down tensions with Catalonia in its bid for EMA – EURACTIV.com

Spain plays down tensions with Catalonia in its bid for EMA

Orphan drugs: Leading the way in patient-centricity

Orphan drugs: Leading the way in patient-centricity

Pinterest
Search